ATP1B3P1

Across TCGA pan-cancer cohorts, ATP1B3P1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated ATP1B3P1 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher ATP1B3P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ATP1B3P1 expression acts as an unfavorable survival marker, although some lineages such as CESC and LUSC show a favorable association.

CESC, MESO, and LIHC are the cancer types where ATP1B3P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Quartile	II,III,IV	0.826	0.427	<.001	54	view →
MESO	DFS	Median	II,III,IV	0.316	0.483	.011	53	view →
LIHC	DFS	Tertile	All	0.381	0.597	<.001	45	view →
UVM	DFS	Quartile	All	0.433	0.788	<.001	39	view →
STAD	DFS	Quartile	II,III,IV	0.325	0.677	.015	38	view →
KICH	OS	Tertile	II,III,IV	0.718	0.936	.012	26	view →
LGG	DFS	Quartile	All	0.747	0.884	.001	23	view →
LUSC	DFS	Median	II,III,IV	0.466	0.271	.010	22	view →
COAD	OS	Quartile	All	0.945	0.602	.004	20	view →
LAML	DFS	Median	All	0.694	0.458	.016	14	view →
BLCA	DFS	Median	III,IV	0.486	0.648	.003	11	view →
GBM	DFS	Quartile	All	0.159	0.289	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

ATP1B3P1–CESC (DFS)

Open the CESC breakdown →